关注
Evangelos Cholongitas
Evangelos Cholongitas
Professor in Medicine-Hepatology, National & Kapodistrian University of Athens
在 med.uoa.gr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies
L Marelli, R Stigliano, C Triantos, M Senzolo, E Cholongitas, N Davies, ...
Cardiovascular and interventional radiology 30, 6-25, 2007
10562007
Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy
EA Tsochatzis, KS Gurusamy, S Ntaoula, E Cholongitas, BR Davidson, ...
Journal of hepatology 54 (4), 650-659, 2011
8842011
Systematic review: the model for end‐stage liver disease–should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis?
E Cholongitas, GV Papatheodoridis, M Vangeli, N Terreni, D Patch, ...
Alimentary pharmacology & therapeutics 22 (11‐12), 1079-1089, 2005
5782005
An appraisal of the histopathological assessment of liver fibrosis
RA Standish, E Cholongitas, A Dhillon, AK Burroughs, AP Dhillon
Gut 55 (4), 569-578, 2006
5472006
Transjugular liver biopsy–indications, adequacy, quality of specimens, and complications–a systematic review
G Kalambokis, P Manousou, S Vibhakorn, L Marelli, E Cholongitas, ...
Journal of hepatology 47 (2), 284-294, 2007
4282007
A systematic review of the performance of the model for end‐stage liver disease (MELD) in the setting of liver transplantation
E Cholongitas, L Marelli, V Shusang, M Senzolo, K Rolles, D Patch, ...
Liver transplantation 12 (7), 1049-1061, 2006
3772006
Liver grafts from anti-hepatitis B core positive donors: a systematic review
E Cholongitas, GV Papatheodoridis, AK Burroughs
Journal of hepatology 52 (2), 272-279, 2010
3422010
A systematic review of the quality of liver biopsy specimens
E Cholongitas, M Senzolo, R Standish, L Marelli, A Quaglia, D Patch, ...
American journal of clinical pathology 125 (5), 710-721, 2006
3302006
Risk factors, sequential organ failure assessment and model for end‐stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive …
E Cholongitas, M Senzolo, D Patch, K Kwong, V Nikolopoulou, G Leandro, ...
Alimentary pharmacology & therapeutics 23 (7), 883-893, 2006
2992006
Discontinuation of oral antivirals in chronic hepatitis B: a systematic review
G Papatheodoridis, I Vlachogiannakos, E Cholongitas, K Wursthorn, ...
Hepatology 63 (5), 1481-1492, 2016
2982016
β‐Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta‐analysis
M Senzolo, E Cholongitas, P Burra, G Leandro, U Thalheimer, D Patch, ...
Liver International 29 (8), 1189-1193, 2009
2932009
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related …
VG Athyros, TK Alexandrides, H Bilianou, E Cholongitas, M Doumas, ...
Metabolism 71, 17-32, 2017
2912017
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation
M Senzolo, J Tibbals, E Cholongitas, CK Triantos, AK Burroughs, D Patch
Alimentary pharmacology & therapeutics 23 (6), 767-775, 2006
2692006
New insights into the coagulopathy of liver disease and liver transplantation
M Senzolo, P Burra, E Cholongitas, AK Burroughs
World journal of gastroenterology: WJG 12 (48), 7725, 2006
2462006
Different methods of creatinine measurement significantly affect MELD scores
E Cholongitas, L Marelli, A Kerry, M Senzolo, DW Goodier, D Nair, ...
Liver Transplantation 13 (4), 523-529, 2007
2122007
Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation
E Cholongitas, V Shusang, GV Papatheodoridis, L Marelli, P Manousou, ...
Liver transplantation 14 (2), 138-143, 2008
2002008
renal function assessment in cirrhosis–difficulties and alternative measurements
E Cholongitas, V Shusang, L Marelli, D Nair, M Thomas, D Patch, A Burns, ...
Alimentary pharmacology & therapeutics 26 (7), 969-978, 2007
1992007
Scoring systems for assessing prognosis in critically ill adult cirrhotics
E Cholongitas, M Senzolo, D Patch, S Shaw, C Hui, AK Burroughs
Alimentary pharmacology & therapeutics 24 (3), 453-464, 2006
1922006
Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review
E Cholongitas, C Mamou, KI Rodríguez‐Castro, P Burra
Transplant International 27 (10), 1039-1049, 2014
1912014
Diagnosis of non-alcoholic fatty liver disease (NAFLD): current concepts
M Papatheodoridi, E Cholongitas
Current pharmaceutical design 24 (38), 4574-4586, 2018
1842018
系统目前无法执行此操作,请稍后再试。
文章 1–20